Remove BioTech Remove healthcare technology Remove Industry
article thumbnail

MDisrupt Secures American Heart Association Ventures Investment, Enters Strategic Collaboration for Association Members

Healthcare IT Today

“Our collaboration with the Association will create valuable opportunities for thousands of members to engage with industry, apply their expertise in new roles, and shape the future of healthcare technology.” MDisrupt has raised $6.6 million to date, including its most recent $3 million in seed funding.

article thumbnail

HealthTech M&A Multiples March 2025: Current Trends and Variables driving valuations

Lloyd Price

Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. in 2023 but still higher than the average revenue multiple for all technology companies, which is 3.5x. Market share:Market share is a measure of a company's dominance in its industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Doximity - the 'Linkedin for Doctors' is the best performing healthcare stock in 2025

Lloyd Price

These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that. Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround. crushed the $0.34

article thumbnail

2021HealthTech IPO Rush: 20+ Digital Health companies went public in 2021 but where are they now?

Lloyd Price

The rapid growth of digital health and the potential for disruption in the healthcare industry made it an attractive investment proposition. Convey Health Solutions:A healthcare technology company that provides risk adjustment, quality improvement, and data analytics services to payers.

article thumbnail

Colin Bower Joins VivoSense as Chief Executive Officer

Digital Health Global

Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions. “I About VivoSense VivoSense, Inc.

BioTech 88
article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.

article thumbnail

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

By embracing technological advancements, focusing on personalised medicine, and addressing the challenges of chronic wounds, the industry can improve patient outcomes, reduce costs, and enhance the overall quality of care. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.